Evidence map›Paper›PMID 29215574›Full record

ArticleMolecules (Basel, Switzerland)2017

Relationship between Antioxidant and Anticancer Activity of Trihydroxyflavones.

Ignas Grigalius, Vilma Petrikaite

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Bioactive Flavonoids fromDrug design, development and therapy · 2026
    Review
  7. Article
  8. Design, Synthesis, and Biological Evaluation ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. The antioxidant and anticancer activity ofSaudi journal of biological sciences · 2024
    Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ignas GrigaliusDepartment of Drug Chemistry, Faculty of Pharmacy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania. ignasgrigalius@gmail.com.ORCID 0000-0001-8252-4008
Vilma PetrikaiteDepartment of Drug Chemistry, Faculty of Pharmacy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania. vilma.petrikaite@lsmuni.lt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant polyphenols have been highlighted not only as chemopreventive, but also as potential anticancer substances. Flavones are a subclass of natural flavonoids reported to have an antioxidant and anticancer activity. The aim of our study was to evaluate antioxidant and anticancer activity of seventeen trihydroxyflavone derivatives, including apigenin (API) and baicalein (BCL). Also, we wanted to find out if there is a correlation between those two effects. Cell growth inhibition testing was carried out using MTT assay in three different human cancer cell lines: lung (A549), breast (MCF-7) and brain epithelial (U87). Antioxidant activity was determined by the DPPH radical scavenging method. Thirteen trihydroxyflavones possessed anticancer activity against at least one tested cancer cell line. They were more active against the MCF-7 cell line, and the lowest activity was determined against the U87 cell line. The majority of compounds inhibited cancer cell growth at EC

conclusionsTrihydroxyflavones demonstrated anticancer activity. Further and more detailed studies should to be carried out to estimate the structure-activity relationship of these compounds.

Indexed as

A549 CellsAntineoplastic Agents, PhytogenicAntioxidantsApigeninBiphenyl CompoundsCell Line, TumorCell SurvivalFlavanonesFlavonoidsHumansInhibitory Concentration 50MCF-7 CellsPicratesStructure-Activity Relationship1,1-diphenyl-2-picrylhydrazyl3',4',7-trihydroxyflavoneAntineoplastic Agents, PhytogenicAntioxidantsApigeninbaicaleinBiphenyl CompoundsFlavanonesFlavonoidsPicratesanticancerantioxidantflavonoidstructure-activity relationshiptrihydroxyflavone

Identifiers

PMID29215574
PMCPMC6149854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.